National Lipid Association (NLA) Scientific Sessions 2024 is a conference that covers topics such as:
- Genetic Disorders (including Hereditary Dyslipidemias)
- Pathophysiology of Atherosclerosis (including Lipoprotein Metabolism)
- Epidemiology of Cardiovascular Disease
- Metabolic Syndrome, Insulin Resistance, Diabetes
- Comprehensive ASCVD Risk Reduction (including hypertension, smoking cessation)
- Inflammation in Atherosclerosis
- Gene Therapy
- Imaging
- Enhancing Adherence to Therapies (including Management of Statin Intolerance)
- Clinical Application of Biomarkers
- Novel Therapies in Lipid Management and Co-Morbidities
- HDL Modification or Novel HDL Therapies
- Lipid Management through Nutrition, Supplements and Lifestyle Therapies (including Omega-3 Fatty Acids)
- Best Practices in Lipid Management (including Clinical Operations, Team-based Care Approaches, Outcomes Research)
- Lipid Management in Special Populations (including COVID-19)
- Lipid Management through Pharmacology
- Diversity, Equity, and Inclusion- research or case studies highlighting underserved populations
- Complex or Unusual Cases in Lipid Management
National Lipid Association (NLA) Scientific Sessions 2024 brings together attendees with an interest in lipid management including:
- Physician assistants
- Physicians
- Registered nurses
- Pharmacists
- Advance practice registered nurses
- Nurse practitioners
- Registered dietitians
